GINO CORTES: Open Payments
NPI 1801527650 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 22 payments from 12 companies in 2025. Trend: 2023 $324 · 2024 $239 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $184 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| Edwards Lifesciences Corporation | 1 | $123 |
| Merck Sharp & Dohme LLC | 4 | $67 |
| Exact Sciences Corporation | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: AIRSUPRA, TZIELD, PASCAL, VERQUVO, VOQUEZNA, Optimizer, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across NV — which companies pay providers there.
